Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$326,671,705
-$11,307,659 QoQ
Shares Held
1,286,261
-7.0% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
1.91%
of 13F equity value
Holder Rank
#141
of 4,664 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$9,777,600
PutShares
40,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GLENMEDE TRUST CO NA holds $996,376,961 across 14 Drug Manufacturers - General names. JNJ ranks #2 (32.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
300,851 | $360,849,743 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,286,261 | $326,671,705 | |
| 3 | ABBV |
AbbVie Inc.
|
323,203 | $81,330,801 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
1,084,726 | $62,501,910 | |
| 5 | MRK |
Merck & Co., Inc.
|
391,031 | $50,247,482 | |
| 6 | AMGN |
Amgen Inc
|
104,523 | $37,849,868 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
199,749 | $25,236,288 | |
| 8 | PFE |
Pfizer Inc
|
793,315 | $19,103,024 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $326,671,705 | 1,286,261 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $337,979,364 | 1,382,668 | Shares | Defined | 2026-05-26 | |
| 2026-03-31 | $9,777,600 | 40,000 | Put | Sole | 2026-05-26 | |
| 2025-12-31 | $290,417,279 | 1,403,321 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $234,868,742 | 1,416,237 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $207,721,175 | 1,436,324 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $269,487,790 | 1,662,889 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $235,755,785 | 1,612,998 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $249,873,442 | 1,579,578 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $258,976,486 | 1,652,268 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $258,798,715 | 1,661,629 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $280,723,078 | 1,696,007 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $262,881,085 | 1,696,007 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $303,170,969 | 1,716,224 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $283,498,211 | 1,735,420 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $307,309,570 | 1,731,224 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $312,190,997 | 1,761,502 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $326,270,689 | 1,907,235 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $309,824,345 | 1,918,417 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $346,791,535 | 2,105,084 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $370,853,473 | 2,256,486 | Shares | Defined | 2021-05-18 | |
| 2020-12-31 | $327,041,146 | 2,078,035 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $290,812,066 | 1,953,332 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $253,800,304 | 1,804,738 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $243,534,897 | 1,857,202 | Shares | Defined | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||